Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath

A. Kikowatz, G. Becher, S. Dietze, W. Steinhaeusser, E. Glaser (Berlin, Wuerzburg, Germany)

Source: Annual Congress 2008 - Assessment of the respiratory system
Session: Assessment of the respiratory system
Session type: Thematic Poster Session
Number: 961

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kikowatz, G. Becher, S. Dietze, W. Steinhaeusser, E. Glaser (Berlin, Wuerzburg, Germany). Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath. Eur Respir J 2008; 32: Suppl. 52, 961

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012

How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS.
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients.
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018




Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012


Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006

Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study
Source: ERJ Open Res, 8 (1) 00493-2021; 10.1183/23120541.00493-2021
Year: 2022



Human skin keratins are the major proteins in exhaled breath condensate
Source: Eur Respir J 2008; 31: 380-384
Year: 2008



The impact of gas analysis technique on the measurement of single breath gas transfer (TLCO)
Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement
Year: 2015


Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018




Real time mass spectrometric analysis of biomarkers in exhaled breath after exposure to an irritant
Source: International Congress 2019 – Indoor and outdoor air quality considerations
Year: 2019